Randox Win IT Team or Department of the Year at the 2022 Belfast Telegraph IT Awards

Home - Archives for 14th November 2022

Randox Win IT Team or Department of the Year at the 2022 Belfast Telegraph IT Awards

https://www.linkedin.com/company/107191

Randox would like to congratulate the IT Department on their Belfast Telegraph IT Awards Win!

 

The Randox IT department were delighted to win the IT Team or Department of the Year award sponsored by Continu. Described as the ‘clear winner’ by Belfast Telegraph, Randox IT won the award due to their hard work and dedication during the Covid-19 pandemic.

The awards took place on Friday at the MAC Theatre in Belfast and was hosted by comedian Neil Delamere. Northern Ireland’s incredible IT industry was showcased displaying their great achievements and their significant, positive impact on the local economy.

In the past 12 months, Randox IT department transformed the cutting-edge systems and facilities created during the pandemic to allow customers to take control of their health through preventative testing.  Randox IT were very much at the forefront of innovation and continued to develop and enhance our offerings, processing 27 million covid results in total. Furthermore, expanding into the travel market and providing an essential service to people who could finally travel to see loved ones after years in isolation.

The team’s disruptive approach to development has allowed Randox to respond quickly in an ever-evolving situation and introduce a full end-to-end testing process facilitating multiple key stages such as, logistics, registration, accessioning, sample processing and results reporting.

At the beginning of 2022, there was a realization that the future landscape for healthcare has changed forever. People want to know the status of their health and are actively taking control of their health and wellbeing. Through these innovate solutions developed by Randox IT in the fight against covid, the team have focused on the future vision of healthcare and developed solutions for customers to test themselves, in clinic or at home, for areas such as heart health, Thyroid health, STI, Vit and Minerals as well as our most popular packages of Everyman, Everywomen, Signature, Every Athlete.

This has only been possible due to the dedication and expertise of the IT team who released a new version of the Randox Health customer platform, which provides each customer with a customized view of their health. Customers have key insights to their health data allowing them to track their health.

 

Randox would like to congratulate the Randox IT Department again on their second year of success at the IT Awards!

Contact Us
Randox IT Team
Rebecca Cuthbert, Karen Gillespie, and Emma McGirk at the Belfast Telegraph IT Awards

Celebrating World Diabetes Day 2022!

Celebrating World Diabetes Day, 14th November 2022!

Diabetes is a serious medical condition that causes blood glucose (sugar) levels to become too high.  This can cause complications such as heart disease, stroke, kidney problems or nerve damage if not treated.

Although there is no cure for Diabetes, the condition can be controlled and monitored.

There are three main types of diabetes, type one, type two and gestational diabetes. The former two are lifelong and can cause life threatening complications if not monitored effectively.

Type one diabetes is when the body can’t make insulin, which is thought to be caused by an autoimmune reaction. In the UK, around 8% of the population have type one.

Type two diabetes is generally caused from lifestyle, when the pancreas doesn’t work properly and can’t keep your blood sugar levels from rising. Type two represents around 90% of people with diabetes in the UK.

Gestational diabetes Mellitus (GDM) is a form of diabetes that appears in pregnancy, characterised by high blood sugar due to the hormones produced in pregnancy. In the UK, around 5% of pregnant women are diagnosed every year.

 

Globally, Diabetes affects more than 415 million people, with type 2 being the most common.

People with T1D have an estimated 50% risk of developing Chronic Kidney Disease over their lifetime. CKD can progress to kidney failure, requiring dialysis or a kidney transplant. Taking a personalized approach to kidney disease screening for people with type 1 diabetes (T1D) may reduce the time that chronic kidney disease (CKD) goes undetected, according to a new analysis performed by the Epidemiology of Diabetes Interventions and Complications study group.

World Diabetes Day aims to increase visibility around the condition and can help sufferers feel less alone. Charities such as Diabetes UK also use the day to help promote awareness and information around the condition to help get people diagnosed earlier through campaigns such as #RewriteTheStory.

 

Randox reagents cover a spectrum of laboratory testing which can help monitor Diabetes and the effectiveness of management. This can help prevent serious complications which can become life threatening.

 

Diagnosis and Monitoring

Fructosamine (Glycated Protein) has been identified as an early indicator of diabetic control compared to other markers such as HbA1c.  HbA1c represents the average blood glucose levels for the previous 2-3 months, conversely fructosamine reflects average blood glucose levels of the previous 2-3 weeks.  HbA1c levels may also be impacted by genetic, haematological and disease-related factors.  The enzymatic Fructosamine method also offers improved specificity and reliability compared to conventional NBT-based methods and does not suffer from non-specific interferences unlike other commercially available Fructosamine assays.

Complications Monitoring – Ketoacidosis

D-3-Hydroxybutyrate (Ranbut) is the most sensitive ketone for the diagnosis of ketosis, in particular diabetic ketoacidosis (DKA) , because it represents approximately 80% of ketones present in blood during DKA. The nitroprusside method commonly used in semi-quantitative dipstick tests only detects acetone and acetoacetate making it less accurate.

Complications Monitoring – Renal Dysfunction

Cystatin C is extremely sensitive to very small changes in GFR and has been identified as a strong predictor of clinical outcomes associated with chronic kidney disease (CKD). Cystatin C doesn’t have a ‘blind area’ like creatinine. Up to 50% of renal function may be lost before significant creatinine elevation occurs. NICE guidelines recommend cystatin C testing due to its higher specificity for significant disease outcomes.

 

To find out more visit: https://www.randox.com/diabetes-reagents/

Or email us at: reagents@randox.com


Request a meeting
×
Make an Enquiry - RX series
×
Make an Enquiry - Reagents
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Kit Insert Request - Reagents
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Reagents
×
Make an Enquiry - Quality Control
×
Make an Enquiry - RIQAS
×
Make an Enquiry - RIQAS
×
Make an Enquiry - Quality Control
×
Make an Enquiry
  • Signing up to our mailing list is quick and easy. We do not wish to send you any spam or junk email, therefore, you can expect to receive mailshots including new product launches and updates, market trends, attendance at key industry events and much more. Randox Laboratories promise never to sell your data and we will keep all your details, safe and secure. Read more in our Privacy Policy.
×
Make an Enquiry - Biochip